This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
5 Hot Tech ETFs to Tap on Beaten Down Prices
by Sweta Killa
Investors should buy the dip in the sector with ETFs that were leading the surge before the sell-off. For them, we have highlighted five hot ETFs that were in red over the past week but have a solid upside potential given the current trends.
Is ARK ETFs' Stellar Journey Over?
by Sanghamitra Saha
ARKK witnessed its worst performance of 2021 on Feb 22, per Bloomberg as rising rates hurt some of its high-flying growth stock holdings.
U.S. Equity & ARK ETFs Top Last Week Inflows, Bonds Lag
by Sweta Killa
Overall, ETFs gathered about $11.5 billion capital last week, bringing in year-to-date inflows of $129.3 billion and higher than $98.3 billion seen in the year-ago period.
5 Stocks That Make Ark Innovation ETF (ARKK) Red Hot
by Sweta Killa
ARKK is centered around the idea of disruptive innovation, which is defined as the introduction of a technologically-enabled new product or service that potentially changes the way the world works.
Weekly ETF Roundup: U.S. Equity Tops, Bond Flops
by Sweta Killa
Overall ETFs gathered about $36.3 billion capital last week, bringing in year-to-date inflows of $117.4 billion, higher than the $89.1 billion seen in the year-ago period,
Zacks Value Trader Highlights: ARKK, QVAL, DEEP, FOVL and RPV
by Zacks Equity Research
Zacks Value Trader Highlights: ARKK, QVAL, DEEP, FOVL and RPV
Using ETFs to Buy Deep Value Stocks
by Tracey Ryniec
The targeted, specialty ETFs are all the rage in 2021. Should value investors be using them to find deep value?
5 Red-Hot ETFs to Gift Your Loved Ones
by Sweta Killa
Valentine's Day is around the corner and while accessories, dresses, gadgets or flowers are the usual gifts being picked up for this day, gifting an ETF could also be a great idea.
GameStop Lessons: Becoming a Savvy Investor with ETFs
by Kevin Cook
As more young investors take up day trading, I have a recipe for long-term wealth creation
Bear of the Day: CRISPR Therapeutics (CRSP)
by Kevin Cook
Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing